Patterns of antimicrobial resistance in a surgical intensive care unit of a university hospital in Turkey

BMC Infectious Diseases

Volumn 6, Issue , 2006, Pages

  Bayram, Aysen ^a   Balci, Iclal ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; METICILLIN; PENICILLIN G; PIPERACILLIN; TETRACYCLINE; TICARCILLIN; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ADULT; ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CANDIDA; COAGULASE POSITIVE STAPHYLOCOCCUS; FUNGAL STRAIN; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRACTICE GUIDELINE; PSEUDOMONAS AERUGINOSA; REVIEW; SURGICAL WARD; TERTIARY HEALTH CARE; TURKEY (REPUBLIC); UNIVERSITY HOSPITAL;

ADULT; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, FUNGAL; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE; MYCOSES; SURGICAL WOUND INFECTION; TURKEY; URINARY TRACT INFECTIONS;

EID: 33750736647     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-6-155     Document Type: Review

References (24)

1. Archibald L, Phillips L, Monnet D, McGowan JE Jr, Tenover F, Gaynes R. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 1997, 24:211-215.
2. Weinstein R: Controlling antimicrobial resistance in hospitals: infection control and use of antibiotics. Emerg Infect Dis 2001, 7:188-191.
3. Streit JM, Jones RN, Sader HS, Fritsche TR: Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). Int J Antimicrob Agents 2004, 24:111-118.
4. Fridkin SK, Hill HA, Volkova NV, Edwards JR, Lawton RM, Gaynes RR, McGowan JE Jr: Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals. Emerg Infect Dis 2002, 8:697-701.
5. Garcia-Rodriguez JA, The MYSTIC Programme Study Group, Jones RN: Antimicrobial resistance in Gram-negative isolates from European intensive care units: data from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme. J Chemother 2002, 14:25-32.
6. Fridkin SK, Edwards JR, Courval JM, Hill H, Tenover FC, Lawton R, Gaynes RP, McGowan JE Jr: The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 US adult intensive care units. Ann Intern Med 2001, 135:175-183.
7. Fluit AC, Verhoef J, The European SENTRY Participants, Schmitz FJ: Frequency of isolation and antimicrobial resistance of Gram-negative and Gram-positive bacteria from patients in intensive care units of 25 European university hospitals participating in the European arm of the SENTRY Antimicrobial Surveillance Program 1997-1998. Eur J Clin Microbiol Infect Dis 2001, 20:617-625.
8. Neuhauser MM, Weinstein RA, Rydman R, Danziger LH, Karam G, Quinn JP: Antibiotic resistance among Gram-negative bacilli in US intensive care units. JAMA 2003, 289:885-888.
9. Mendes C, Oplustil C, Sakagami E, Turner P, Kiffer C, The MYSTIC Brazil Group: Antimicrobial Susceptibility in Intensive Care Units: MYSTIC Program Brazil 2002. Brazilian J Infect Dis 2005, 9:44-51.
10. Mendes C, Turner PJ: Unit differences in pathogen occurrence arising from the MYSTIC program European database (1997-2000). Diagn Microbiol Infect Dis 2001, 41:191-196.
11. Pfaller MA, Jones RN, Biedenbach DJ: Antimicrobial resistance trends in medical centers using carbapenems: report of 1999 and 2000 results from the MYSTIC program (USA). Diagn Microbiol Infect Dis 2001, 41:177-182.
12. Diekema DJ, Pfaller MA, Jones RN, Doern GV, Winokur PL, Gales AC, Sader HS, Kugler K, Beach M: Survey of bloodstream infection due to Gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada and Latin America for the SENTRY Antimicrobial Surveillance Program 1997. Clin Infect Dis 1997, 29:595-607.
13. Diekema DJ, Pfaller MA, Jones RN, Doern GV, Kugler K, Beach ML, Sader HS: Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infection in the USA, Canada and Latin America. SENTRY Participants Group. Int J Antimicrob Agents 2000, 13:257-271.
14. Fridkin SK, Gaynes RP: Antimicrobial resistance in intensive care units. Clinics in Chest Medicine 1999, 20:303-316.
15. Aubry-Damon H, Courvalin P, Bacterial Resistance to Antimicrobial Agents: Selected Problems in France, 1996 to 1998. Emerg Infect Dis 1999, 5:315-320.
16. Friedland I, Gallagher G, King T, Woods GL: Antimicrobial susceptibility patterns in Pseudomonas aeruginosa: data from a multicenter Intensive Care Unit Surveillance Study (ISS) in the United States. J Chemother 2004, 16:437-441.
17. Lortholary O, Fagon JY, Hoi AB, Slama MA, Pierre J, Giral P, Rosenzweig R, Gutmann L, Safar M, Acar J: Nosocomial acquisition of multi-resistant Acinetobacter baumannii: Risk factors and prognosis. Clin Infect Dis 1995, 20:790-796.
18. Seifert H, Baginski R, Schulze A, Pulverer G: Antimicrobial susceptibility of Acinetobacter species. Antimicrob Agents Chemother 1993, 37:750-753.
19. Eisenstein BI, Zaleznik DF: Enterobacteriaceae. In Principles and Practice of Infectious Diseases Edited by: Mandell GL, Bennett JE, Dolin R. Churchill Livingstone; 2000.
20. Pfaller MA, Jones RN, Marshall SA, Coffman SL, Hollis RJ, Edmond MB, Wenzel RP: Inducible amp C beta-lactamase producing gram-negative bacilli from blood stream infections: Frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE). Diagn Microbial Infect Dis 1997, 28:211-219.
21. Shlaes DM, Gerding DN, John JF Jr, Craig WA, Bornstein DL, Duncan RA, Eckman MR, Farrer WE, Greene WH, Lorian V, Levy S, McGowan JE Jr, Paul SM, Ruskin J, Tenover FC, Watanakunakorn C: Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol 1997, 18:275-291.
22. Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE Jr, Archibald LK, Gaynes RP, Tenover FC: Surveillance of antimicrobial use and antimicrobial resistance in US hospital: project ICARE Phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 1999, 29:245-252.
23. Richards MJ, Edwards JR, Culver DH, Gaynes RP: Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 1999, 27:887-892.
24. NCCLS: Performance Standards for Antimicrobial Susceptibility Testing: eleventh Informational supplement M100-S13. NCCLS Wayne Pa 2003.